Trial Profile
A Multi-Center, Randomized, Double-Blind, Placebo Controlled Study, Tolerability, and Efficacy of Rilonacept for the Prevention of Gout Flares During Initiation of Allopurinol Therapy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 May 2017
Price :
$35
*
At a glance
- Drugs Rilonacept (Primary)
- Indications Gout
- Focus Therapeutic Use
- Sponsors Regeneron Pharmaceuticals
- 04 Jan 2012 Results published in Arthritis and Rheumatism.
- 03 Mar 2011 Results of a substudy determining the minimally important difference estimates for the Gout Impact Scale published in the Rheumatology.
- 23 Nov 2009 Results presented at the 73rd Annual Scientific Meeting of the American College of Rheumatology and the 44th Annual Meeting of the Association of Rheumatology Health Professionals.